RE:InMed To Acquire BayMedica In All-Stock Transaction Pegged ABayMedicas Chief Executive Officer, Shane Johnson, stated, The entire BayMedica team is very excited to join InMed. We look forward to advancing our manufacturing systems together, enabling us to bring additional rare cannabinoids to the market, and to leverage our technology and IP to directly contribute to InMeds clinical development pipeline. The timing of this acquisition is ideal given our plans for several high value product launches.